Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries-Reference-Cited by-同舟云学术

Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries

Published:2017-02 Issue:2 Volume:76 Page:299-308.e16
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Garcia-Doval Ignacio^ORCID,Cohen Arnon D.,Cazzaniga Simone^ORCID,Feldhamer Ilan,Addis Antonio,Carretero Gregorio,Ferrándiz Carlos,Stern Robert S.,Naldi Luigi^ORCID

Publisher

Elsevier BV

Subject

Dermatology

Reference26 articles.

1. International Conference on Harmonization. International Conference on Harmonization E2A guideline 1994. Available from: URL: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf. Accessed July 1, 2016.

2. Risk of serious infections in patients with psoriasis on biologic therapies: a systematic review and meta-analysis;Yiu;J Invest Dermatol,2016

3. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register;Dixon;Arthritis Rheum,2006

4. The risk of deep fungal infections during biologic therapy for psoriasis;Jourabchi;J Eur Acad Dermatol Venereol,2014

5. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report;Gomez-Reino;Arthritis Rheum,2003

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapy for psoriasis and the risk of cutaneous infections;The Journal of Dermatology;2024-04-25

2. Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities;Journal of Clinical Medicine;2024-01-16

3. Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies;Dermatology and Therapy;2023-12-03

4. Temporal dynamics of skin microbiota and immune correlates in psoriasis patients receiving systemic treatment;2023-11-27

5. Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors – A population‐based study;Journal of the European Academy of Dermatology and Venereology;2023-07-19